Compounding Lobby Calls FDA’s Marketing Blitz ‘Misleading’

Drug Industry Daily
A A
The compounding pharmacy lobby is pushing back against the FDA’s campaign to encourage hospitals to buy compounded drugs only from agency-registered sites as disingenuous and misleading, saying the products aren’t necessarily safer for patients.

To View This Article:

Login

Subscribe To Drug Industry Daily